Quick Answer
IMMUCELL CORP /DE/ reported Long Term Debt of $7.49 million for the year ending 2025.
- IMMUCELL CORP /DE/ showed a decrease of -17.2% in Long Term Debt from 2024 to 2025.
- This data is from IMMUCELL CORP /DE/'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2011 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2012: $1.22 million | Q1 2013: $1.11 million | Q2 2013: $1.04 million | Q3 2013: $987.9 thousand | Q4 2013: $929.2 thousand | Q1 2014: $882.5 thousand | Q2 2014: $838.8 thousand | Q2 2025: $8.26 million | Q3 2025: $7.90 million.
- Over the full 5 years of available data (2011 to 2025), IMMUCELL CORP /DE/'s Long Term Debt has grown by 460.6%.
- Historical annual values: Fiscal year 2025: $7.49 million | Fiscal year 2024: $9.04 million | Fiscal year 2013: $929.2 thousand | Fiscal year 2012: $1.17 million | Fiscal year 2011: $1.34 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: